Resultaten visas 1 - 10 / 368
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År

Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland

Referentgranskad
Öppen tillgång
DOI
10.1111/1759-7714.14146
Torkki, Paulus; Paajanen, Juuso; Kytö, Ville; Laaksonen, Sanna; Räsänen, Jari; Myllärniemi, Marjukka...
Thoracic cancer2021

Prognostic factors in malignant pleural mesothelioma

Öppen tillgång
Paajanen, Juuso
[J. Paajanen]2020

Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma

Referentgranskad
DOI
10.1016/j.jtho.2022.03.012
Laaksonen, Sanna; Kettunen, Eeva; Sutinen, Eva; Ilonen, Ilkka; Vehmas, Tapio; Törmäkangas, Timo; Räs...
Journal of thoracic oncology2022

Malignant pleural mesothelioma-epidemiology and pulmonary asbestos fibers : a National Cancer Registry cohort study

Öppen tillgång
Laaksonen, Sanna
Helsingin yliopisto2022

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.

Referentgranskad
Öppen tillgång
DOI
10.1186/s12885-019-5652-y
Kettunen, Eeva; Savukoski, Sauli; Salmenkivi, Kaisa; Böhling, Tom; Vanhala, Esa; Kuosma, Eeva; Antti...
Bmc cancer2019

Malignant pleural mesothelioma in Finland:regional and gender variation

Referentgranskad
Öppen tillgång
DOI
10.1080/0284186X.2018.1532599
Laaksonen, Sanna; Ilonen, Ilkka; Kuosma, Eeva; Sutinen, Eva; Wolff, Henrik; Vehmas, Tapio; Husgafvel...
Acta oncologica2019

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13

Referentgranskad
Öppen tillgång
DOI
10.3390/cells12060929
Martinez-Fernandez, Carmen; Jha, Sweta; Aliagas, Elisabet; Holmberg, Carina I.; Nadal, Ernest; Ceron...
Cells2023

Pemetrexed in malignant pleural mesothelioma and the clinical outcome

Referentgranskad
Knuuttila, Aija Hannele; Salomaa, Eija-Riitta; Saikkonen, Suvi; Hurme, Saija; Salo, Jarmo Antero
Clinical respiratory journal2012

Pemetrexed in malignant pleural mesothelioma and the clinical outcome

Referentgranskad
Knuutila A;Salomaa ER;Saikkonen S;Hurme S;Salo J
Clinical Respiratory Journal2012

Pemetrexed in malignant pleural mesothelioma and the clinical outcome

Referentgranskad
Knuuttila A;Salomaa ER;Saikkonen S;Hurme S;Salo J
CLINICAL RESPIRATORY JOURNAL2011

Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland

Referentgranskad
Öppen tillgång
DOI
10.1111/1759-7714.14146
2021

Prognostic factors in malignant pleural mesothelioma

Öppen tillgång
2020

Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma

Referentgranskad
DOI
10.1016/j.jtho.2022.03.012
2022

Malignant pleural mesothelioma-epidemiology and pulmonary asbestos fibers : a National Cancer Registry cohort study

Öppen tillgång
2022

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.

Referentgranskad
Öppen tillgång
DOI
10.1186/s12885-019-5652-y
2019

Malignant pleural mesothelioma in Finland:regional and gender variation

Referentgranskad
Öppen tillgång
DOI
10.1080/0284186X.2018.1532599
2019

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13

Referentgranskad
Öppen tillgång
DOI
10.3390/cells12060929
2023

Pemetrexed in malignant pleural mesothelioma and the clinical outcome

Referentgranskad
2012

Pemetrexed in malignant pleural mesothelioma and the clinical outcome

Referentgranskad
2012

Pemetrexed in malignant pleural mesothelioma and the clinical outcome

Referentgranskad
2011